Invited review: The role of cow, pathogen, and treatment regimen in the therapeutic success of bovine Staphylococcus aureus mastitis

Journal of Dairy Science

Volumn 89, Issue 6, 2006, Pages 1877-1895

  Barkema, H W ^a   Schukken, Y H ^b   Zadoks, R N ^b  

^a UNIVERSITY OF PRINCE EDWARD ISLAND   (Canada)

^b Department of Obstetrics Gynecology   (United States)

Author keywords

Cure; Mastitis; Staphylococcus aureus; Treatment

Indexed keywords

ANIMALIA; BACTERIA (MICROORGANISMS); BOS TAURUS; STAPHYLOCOCCUS AUREUS;

ANTIINFECTIVE AGENT; PENICILLIN DERIVATIVE;

AGING; ANIMAL; ANIMAL DISEASE; CATTLE; CATTLE DISEASE; CELL COUNT; CLINICAL TRIAL; COST; CYTOLOGY; DRUG COMBINATION; ECONOMICS; FEMALE; LACTATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MILK; PENICILLIN RESISTANCE; PREGNANCY; REVIEW; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TIME;

AGING; ANIMALS; ANTI-BACTERIAL AGENTS; CATTLE; CELL COUNT; CLINICAL TRIALS; COSTS AND COST ANALYSIS; DRUG THERAPY, COMBINATION; FEMALE; LACTATION; MASTITIS, BOVINE; MICROBIAL SENSITIVITY TESTS; MILK; PENICILLIN RESISTANCE; PENICILLINS; PREGNANCY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TIME FACTORS;

EID: 33747623729     PISSN: 00220302     EISSN: None     Source Type: Journal    
DOI: 10.3168/jds.S0022-0302(06)72256-1     Document Type: Review

References (133)

1. Aarestrup, F. M., C. A. Dangler, and L. M. Sordillo. 1995. Prevalence of coagulase gene polymorphism in Staphylococcus aureus isolates causing bovine mastitis. Can. J. Vet. Res. 59:124-128.
2. Allore, H. G., and H. N. Erb. 1998. Partial budget of the discounted annual benefit of mastitis control strategies. J. Dairy Sci. 81:2280-2291.
3. Allore, H. G., H. N. Erb, L. W. Schruben, and P. A. Oltenacu. 1998. A simulation of strategies to lower bulk tank somatic cell count below 500,000 per milliliter. J. Dairy Sci. 81:694-702.
4. Alluwaimi, A. M. 2004. The cytokines of bovine mammary gland: Prospects for diagnosis and therapy. Res. Vet. Sci. 77:211-222.
5. Barkema, H. W., H. A. Deluyker, Y. H. Schukken, and T. J. G. M. Lam. 1999. Quarter-milk somatic cell count at calving and at the first milking after calving. Prev. Vet. Med. 38:1-9.
6. Barkema, H. W., Y. H. Schukken, T. J. Lam, D. T. Galligan, M. L. Beiboer, and A. Brand. 1997. Estimation of interdependence among quarters of the bovine udder with subclinical mastitis and implications for analysis. J. Dairy Sci. 80:1592-1599.
7. Barkema, H. W., Y. H. Schukken, T. J. G. M. Lam, M. L. Beiboer, H. Wilmink, G. Benedictus, and A. Brand. 1998a. Incidence of clinical mastitis in dairy herds grouped in three categories by bulk milk somatic cell counts. J. Dairy Sci. 81:411-419.
8. Barkema, H. W., Y. H. Schukken, T. J. G. M. Lam, M. L. Beiboer, G. Benedictus, and A. Brand. 1998b. Management practices associated with low, medium, and high somatic cell counts in bulk milk. J. Dairy Sci. 81:1917-1927.
9. Barlow, J., C. Nightingale, R. Zadoks, L. White, and Y. H. Schukken. 2005. Direct and indirect effects of subclinical mastitis treatment in dairy herds. Page 321-326 in Proc. 4th Int. Dairy Fed. Mastitis Seminar, Maastricht, The Netherlands. Wageningen Acad. Publ., Wageningen, The Netherlands.
10. Borm, A. A., L. K. Fox, K. E. Leslie, J. S. Hogan, S. M. Andrew, S. P. Oliver, Y. H. Schukken, D. D. Hancock, C. T. Gaskins, W. E. Owens, and C. Norman. 2005. Prepartum intramammary antibiotic therapy: Effects on udder health, milk production, and reproductive performance in dairy heifers. Page 364-369 in Proc. 4th Int. Dairy Fed. Mastitis Seminar, Maastricht, The Netherlands. Wageningen Acad. Publ., Wageningen, The Netherlands.
11. Broadbent, J. R., Y. C. Chou, K. Gillies, and J. K. Kondo. 1989. Nisin inhibits several gram-positive, mastitis-causing pathogens. J. Dairy Sci. 72:3342-3345.
12. Brouillette, E., A. Martinez, B. J. Boyll, N. E. Allen, and F. Malouin. 2004. Persistence of a Staphylococcus aureus small-colony variant under antibiotic pressure in vivo. FEMS Immunol. Med. Microbiol. 41:35-41.
13. Buelow, K. L., C. B. Thomas, W. J. Goodger, K. V. Nordlund, and M. T. Collins. 1996. Effect of milk sample collection strategy on sensitivity and specificity of bacteriologic culture and somatic cell count for detection of Staphylococcus aureus intramammary infection in dairy cattle. Prev. Vet. Med. 26:1-8.
14. Constable, P. D., and D. E. Morin. 2003. Treatment of clinical mastitis: Using antimicrobial susceptibility profiles for treatment decisions. Vet. Clin. North Am. Food Anim. Pract. 19:139-155.
15. Costa, E. O., N. R. Benites, J. L. Guerra, and P. A. Melvilla. 2000. Antimicrobial susceptibility of Staphylococcus aureus spp. isolated from mammary parenchymas of slaughtered dairy cows. J. Vet. Med. B 47:99-103.
16. Coughlin, R., L. Tikofsky, H. Schulte, G. Bennett, J. Rejman, D. Fisher, J. Crabb, and Y. Schukken. 2004. Lactation therapy with the nisin-based product MastOut: Results of a 125-cow study. Pages 296-297 in Proc. 43rd Ann. Mtg. Natl. Mastitis Counc., Charlotte, NC. Natl. Mastitis Counc., Madison, WI.
17. Craven, N. 1987. Efficacy and financial value of antibiotic treatment of bovine clinical mastitis during lactation - A review. Br. Vet. J. 143:410-422.
18. Cucarella, C., M. A. Tormo, C. Ubeda, M. P. Trotonda, M. Monzon, C. Peris, B. Amorena, I. Lasa, and J. R. Penades. 2004. Role of biofilm-associated protein bap in the pathogenesis of bovine Staphylococcus aureus. Infect. Immun. 72:2177-2185.
19. DeGraves, F. J., and J. Fetrow. 1993. Economics of mastitis and mastitis control. Vet. Clin. North Am. Food Anim. Pract. 9:421-434.
20. Deluyker, H. A., S. T. Chester, and S. N. Van Oye. 1999. A multilocation clinical trial in lactating dairy cows affected with clinical mastitis to compare the efficacy of treatment with intramammary infusions of a lincomycin/neomycin combination with an ampicillin/cloxacillin combination. J. Vet. Pharmacol. Ther. 22:274-282.
21. Deluyker, H. A., S. N. Van Oye, and J. F. Boucher. 2005. Factors affecting cure and somatic cell count after pirlimycin treatment of subclinical mastitis in lactating cows. J. Dairy Sci. 88:604-614.
22. De Oliveira, A. P., J. L. Watts, S. L. Salmon, and F. M. Aarestrup. 2000. Antimicrobial susceptibility of Staphylococcus aureus isolated from bovine mastitis in Europe and the United States. J. Dairy Sci. 83:855-862.
23. Diarra, M. S., D. Petitclerc, and P. Lacasse. 2002. Effect of lactoferrin in combination with penicillin on the morphology and the physiology of Staphylococcus aureus isolated from bovine mastitis. J. Dairy Sci. 85:1141-1149.
24. Dingwell, R. T., K. E. Leslie, T. F. Duffield, Y. H. Schukken, L. DesCoteaux, G. P. Keefe, D. F. Kelton, K. D. Lissemore, W. Shewfelt, P. Dick, and R. Bagg. 2003. Efficacy of intramammary tilmicosin and risk factors for cure of Staphylococcus aureus infection in the dry period. J. Dairy Sci. 86:159-168.
25. Dingwell, R. T., K. E. Leslie, J. Pacan, D. Lepp, and P. Sabour. 2004. The influence of the pulsed-field gel electrophoresis molecular type of subclinical Staphylococcus aureus on dry period elimination in Canadian dairy herds. Proc. 43rd Ann. Mtg. Natl. Mastitis Counc., Charlotte, NC. Natl. Mastitis Counc., Madison, WI.
26. Edmondson, P. W. 1989. An economic justification of "blitz" therapy to eradicate Streptococcus agalactiae from a dairy herd. Vet. Rec. 125:591-593.
27. Edmondson, P. W. 1997. Clinical mastitis in dairy cows after 'blitz' therapy. Vet. Rec. 141:108.
28. Enright, M. C., and B. G. Spratt. 1999. Multilocus sequence typing. Trends Microbiol. 7:482-487.
29. Erskine, R. J. 2000. Antimicrobial drug use in bovine mastitis. Pages 712-734 in Antimicrobial Therapy in Veterinary Medicine. 3rd ed. J. F. Prescott, J. D. Baggot, and R. D. Walker, ed. Blackwell Publishing, Ames IA.
30. Erskine, R. J., J. Cullor, M. Schaellibaum, R. Yancey, and A. Zecconi. 2004. Bovine mastitis pathogens and trends in resistance to antimicrobial drugs. National Mastitis Council. http://www.nmconline.org/docs/ResPaper.pdf Accessed Mar. 28, 2006.
31. Erskine, R. J., and R. J. Eberhart. 1988. Comparison of duplicate and single quarter milk samples for the identification of intramammary infections. J. Dairy Sci. 71:854-856.
32. Erskine, R. J., S. A. Wagner, and F. J. DeGraves. 2003. Mastitis therapy and pharmacology. Vet. Clin. North Am. Food Anim. Pract. 19:109-138.
33. Erskine, R. J., R. D. Walker, C. A. Bolin, P. C. Bartlett, and D. G. White. 2002. Trends in antibacterial susceptibility of mastitis pathogens during a seven-year period. J. Dairy Sci. 85:1111-1118.
34. Fox, L. K., R. N. Zadoks, and C. T. Gaskins. 2005. Biofilm production by Staphylococcus aureus associated with intramammary infection. Vet. Microbiol. 107:295-299.
35. Friton, G. M., A. Sobiraj, and A. Richter. 1998. Effects of various antibiotic treatments of lactating cows with subclinical mastitis. Tierarzl. Prax. Ausg. G Grosstiere Nutztiere 26:254-260.
36. Gill, S. R., D. E. Fouts, G. L. Archer, E. F. Mongodin, R. T. Deboy, J. Ravel, I. T. Paulsen, J. F. Kolonay, L. Brinkac, M. Beanan, R. J. Dodson, S. C. Daugherty, R. Madupu, S. V. Angiuoli, A. S. Durkin, D. H. Haft, J. Vamathevan, H. Khouri, T. Utterback, C. Lee, G. Dimitrov, L. Jiang, H. Qin, J. Weidman, K. Tran, K. Kang, I. R. Hance, K. E. Nelson, and C. M. Fraser. 2005. Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain. J. Bacteriol. 187:2426-2438.
37. Gillespie, B. E., H. Moorehead, P. Lunn, H. H. Dowlen, D. L. Johnson, K. C. Lamar, M. J. Lewis, S. J. Ivey, J. W. Hallberg, S. T. Chester, and S. P. Oliver. 2002. Efficacy of extended pirlimycin hydrochloride therapy for treatment of environmental Streptococcus spp. and Staphylococcus aureus intramammary infections in lactating dairy cows. Vet. Ther. 3:373-380.
38. Godden, S. M., J. T. Jansen, K. E. Leslie, N. L. Smart, and D. F. Kelton. 2002. The effect of sampling time and sample handling on the detection of Staphylococcus aureus in milk from quarters with subclinical mastitis. Can. Vet. J. 43:38-42.
39. Goodger, W. J., and G. Ferguson. 1987. Benefits and costs of a control program for an epizootic of Staphylococcus aureus mastitis. J. Am. Vet. Med. Assoc. 190:1284-1287.
40. Guidry, A., A. Fattom, A. Pattel, C. O'Brien, S. Shepherd, and J. Lohuis. 1998. Serotyping scheme for Staphylococcus aureus isolated from cows with mastitis. Am. J. Vet. Res. 59:1537-1539.
41. Guterbock, W. M., A. L. Van Eenennaam, R. J. Anderson, I. A. Gardner, J. S. Cullor, and C. A. Holmberg. 1993. Efficacy of intramammary antibiotic therapy for treatment of clinical mastitis caused by environmental pathogens. J. Dairy Sci. 76:3437-3444.
42. Haveri, M., S. Suominen, L. Rantala, T. Honkanen-Buzalski, and S. Pyörälä. 2005a. Comparison of phenotypic and genotypic detection of penicillin G resistance of Staphylococcus aureus isolated from bovine intramammary infection. Vet. Microbiol. 106:97-102.
43. Haveri, M., S. Taponen, J. Vuopio-Varkila, S. Salmenlinna, and S. Pyörälä. 2005b. Bacterial genotype affects the manifestation and persistence of bovine Staphylococcus aureus intramammary infection. J. Clin. Microbiol. 43:959-961.
44. Hensen, S. M. 2000. Bovine Staphylococcus aureus mastitis - bacterial adhesion and invasion in relation to pathogenesis and antimicrobial sensitivity. PhD Thesis, Utrecht University, The Netherlands.
45. Hensen, S. M., M. J. Pavicic, J. A. Lohuis, and B. Poutrel. 2000. Use of bovine primary mammary epithelial cells for the comparison of adherence and invasion ability of Staphylococcus aureus strains. J. Dairy Sci. 83:418-429.
46. Hillerton, J. E., A. J. Bramley, R. T. Staker, and C. H. McKinnon. 1995. Patterns of intramammary infection and clinical mastitis over a 5 year period in a closely monitored herd applying mastitis control measures. J. Dairy Res. 62:39-50.
47. Hillerton, J. E., and K. E. Kliem. 2002. Effective treatments of Streptococcus uberis clinical mastitis to minimize the use of antibiotics. J. Dairy Sci. 85:1009-1014.
48. Holden, M. T., E. J. Feil, J. A. Lindsay, S. J. Peacock, N. P. Day, M. C. Enright, T. J. Foster, C. E. Moore, L. Hurst, R. Atkin, A. Barron, N. Bason, S. D. Bentley, C. Chillingworth, T. Chillingworth, C. Churcher, L. Clark, C. Corton, A. Cronin, J. Doggett, L. Dowd, T. Feltwell, Z. Hance, B. Harris, H. Hauser, S. Holroyd, K. Jagels, K. D. James, N. Lennard, A. Line, R. Mayes, S. Moule, K. Mungall, D. Ormond, M. A. Quail, E. Rabbinowitsch, K. Rutherford, M. Sanders, S. Sharp, M. Simmonds, K. Stevens, S. Whitehead, B. G. Barrell, B. G. Spratt, and J. Parkhill. 2004. Complete genomes of two clinical Staphylococcus aureus strains: Evidence for the rapid evolution of virulence and drug resistance. Proc. Natl. Acad. Sci. USA 101:9786-9791.
49. Houben, F. H., R. B. Huirne, A. A. Dijkhuizen, and A. R. Kristensen. 1994. Optimal replacement of mastitic cows determined by a hierarchic Markov process. J. Dairy Sci. 77:2975-2993.
50. Hu, S., C. Concha, A. Johannisson, G. Meglia, and K. P. Waller. 2001. Effect of subcutaneous injection of ginseng on cows with subclinical Staphylococcus aureus mastitis. J. Vet. Med. B. Infect. Dis. Public Health 48:519-528.
51. Hwang, C. Y., S. I. Pak, and H. R. Han. 2000. Effects of autogenous toxoid-bacterin in lactating cows with Staphylococcus aureus subclinical mastitis. J. Vet. Med. Sci. 62:875-880.
52. Ito, T., K. Okuma, X. X. Ma, H. Yuzawa, and K. Hiramatsu. 2003. Insights on antibiotic resistance of Staphylococcus aureus from its whole genome: Genomic island SCC. Drug Resist. Updat. 6:41-52.
53. Janosi, S., A. Huszenicza, T. Horvath, F. Gemes, M. Kulcsar, and G. Huszenicza. 2001. Bacteriological recovery after intramuscular or intracisternal spiramycin-based drying-off therapy. Acta Vet. Hung. 49:155-162.
54. Karreman, H. J. 2004. Treating dairy cows naturally: Thoughts and strategies. Paradise Publications, Paradise, PA.
55. Kerro Dogo, O., J. E. van Dijk, and H. Nederbragt. 2002. Factors involved in the early pathogenesis of bovine Staphylococcus aureus mastitis with emphasis on bacterial adhesion and invasion. A review. Vet. Q. 24:181-198.
56. Lam, T. J. G. M., M. C. M. de Jong, Y. H. Schukken, and A. Brand. 1996b. Mathematical modeling to estimate efficacy of postmilking teat disinfection in split-udder trials of dairy cows. J. Dairy Sci. 79:62-70.
57. Lam, T. J. G. M., L. A. van Wuijckhuise, P. Franken, M. L. Morselt, E. G. Hartman, and Y. H. Schukken. 1996a. Use of composite milk samples for diagnosis of Staphylococcus aureus mastitis in dairy cattle. J. Am. Vet. Med. Assoc. 208:1705-1708.
58. Lammers, A. 2000. Pathogenesis of Staphylococcus aureus mastitis. In vitro studies on adhesion, invasion and gene expression. PhD Thesis, Utrecht University, The Netherlands.
59. Lammers, A., P. J. Nuijten, and H. E. Smith. 1999. The fibronectin binding proteins of Staphylococcus aureus are required for adhesion to and invasion of bovine mammary gland cells. FEMS Microbiol. Lett. 180:103-109.
60. Loeffler, S. H., T. J. G. M. Lam, H. W. Barkema, D. Scholten, A. L. Hessels, and A. M. van Gestel. 1995. The dairying veterinary approach to a high bulk milk cell count caused by Streptococcus agalactiae. Tijdschr. Diergeneeskd. 120:458-463.
61. Lohuis, J. A. C. M., S. M. Hensen, and H. Beers. 1995. MIC's and combined activity of penicillin and neomycin against Staphylococcus aureus strains from bovine mastitis as determined by microdilution and checkerboard assay. Proc. 3rd Int. Mastitis Seminar, Tel Aviv, Israel, Session 5:114-115.
62. Luby, C. D., and J. R. Middleton. 2005. Efficacy of vaccination and antibiotic therapy against Staphylococcus aureus mastitis in dairy cattle. Vet. Rec. 157:89-90.
63. Makovec, J. A., and P. L. Ruegg. 2003. Antimicrobial resistance of bacteria isolated from dairy cow milk samples submitted for bacterial culture: 8,905 samples (1994-2001). J. Am. Vet. Med. Assoc. 222:1582-1589.
64. Middleton, J. R., and L. K. Fox. 2001. Influence of Staphylococcus aureus strain on mammary quarter milk production. Pages 179-180 in Proc. 39th Annu. Mtg. Natl. Mastitis Counc., Atlanta, GA. Natl. Mastitis Counc., Madison, WI.
65. Mullarky, I. K., C. Su, N. Frieze, Y. H. Park, and L. M. Sordillo. 2001. Staphylococcus aureus agr genotypes with enterotoxin production capabilities can resist neutrophil bactericidal activity. Infect. Immun. 69:45-51.
66. Myllys, V., K. Aplund, E. Brofeld, V. Horvila-Koski, T. Honkanen-Buzalski, J. Junttila, L. Kulkas, O. Myllyangas, M. Niskanen, H. Saloniemi, M. Sandholm, and T. Saranpaa. 1998. Bovine mastitis in Finland in 1988 and 1995 - Changes in prevalence and antimicrobial resistance. Acta Vet. Scand. 39:119-126.
67. National Mastitis Council. 2001. National Mastitis Council Recommended Mastitis Control Program. http://www.nmconline.org/docs/NMC10steps.pdf Accessed Mar. 28, 2006.
68. Neave, F. K., F. H. Dodd, R. G. Kingwill, and D. R. Westgarth. 1969. Control of mastitis in the dairy herd by hygiene and management. J. Dairy Sci. 52:696-707.
69. Nickerson, S. C., W. E. Owens, and R. L. Boddie. 1995. Mastitis in dairy heifers: Initial studies on prevalence and control. J. Dairy Sci. 78:1607-1618.
70. Oliver, S. P., B. E. Gillespie, S. J. Ivey, M. J. Lewis, D. L. Johnson, K. C. Lamar, H. Moorehead, H. H. Dowlen, S. T. Chester, and J. W. Hallberg. 2004. Influence of prepartum pirlimycin hydrochloride or penicillin-novobiocin therapy on mastitis in heifers during early lactation. J. Dairy Sci. 87:1727-1731.
71. Oliver, S. P., M. J. Lewis, B. E. Gillespie, and H. H. Dowlen. 1992. Influence of prepartum antibiotic therapy on intramammary infections in primigravid heifers during early lactation. J. Dairy Sci. 75:406-414.
72. Oliver, S. P., M. J. Lewis, B. E. Gillespie, H. H. Dowlen, E. C. Jaenicke, and R. K. Roberts. 2003. Prepartum antibiotic treatment of heifers: Milk production, milk quality and economic benefit. J. Dairy Sci. 86:1187-1193.
73. Osteras, O., V. L. Edge, and S. W. Martin. 1999. Determinants of success or failure in the elimination of major mastitis pathogens in selective dry cow therapy. J. Dairy Sci. 82:1221-1231.
74. Owens, W. E., and S. C. Nickerson. 1989. Morphologic study of Staphylococcus aureus L-form, reverting, and intermediate colonies in situ. J. Clin. Microbiol. 27:1382-1386.
75. Owens, W. E., S. C. Nickerson, R. L. Boddie, G. M. Tomita, and C. H. Ray. 2001. Prevalence of mastitis in dairy heifers and effectiveness of antibiotic therapy. J. Dairy Sci. 84:814-817.
76. Owens, W. E., and C. H. Ray. 1996. Therapeutic and prophylactic effect of prepartum antibiotic infusion in heifers. Zentralbl. Veterinarmed. B. 43:455-459.
77. Owens, W. E., C. H. Ray, R. L. Boddie, and S. C. Nickerson. 1988. Antibiotic treatment of mastitis: Comparison of intramammary and intramammary plus intramuscular therapies. J. Dairy Sci. 71:3143-3147.
78. Owens, W. E., C. H. Ray, R. L. Boddie, and S. C. Nickerson. 1997. Efficacy of sequential intramammary antibiotic treatment against chronic Staphylococcus aureus intramammary infection. Large Anim. Pract. 18:10-14.
79. Persson Waller, K., U. Gronlund, and A. Johannisson. 2003. Intramammary infusion of beta 1,3-glucan for prevention and treatment of Staphylococcus aureus mastitis. J. Vet. Med. B Infect. Dis. Vet. Public Health 50:121-127.
80. Poelarends, J. J., H. Hogeveen, O. C. Sampimon, and J. Sol. 2001. Monitoring subclinical mastitis in Dutch dairy herds. Pages 145-149 in Proc. 2nd Int. Symp. Mastitis and Milk Quality, Vancouver, BC, Canada. National Mastitis Counc., Madison, WI.
81. Pyörälä, S. 2005. Letter to the Editor: Concerning an article comparing the efficacy of local and systemic treatment of clinical mastitis. J. Dairy Sci. 88:1617.
82. Pyörälä, S. H., and E. O. Pyörälä. 1998. Efficacy of parenteral administration of three antimicrobial agents in treatment of clinical mastitis in lactating cows: 487 cases (1989-1995). J. Am. Vet Med. Assoc. 212:407-412.
83. Remmen, J. W. A., J. M. J. van de Laar, and F. H. J. Jaartsveld 1982. The effect of treatment with Nafpenzal MC of all cows with subclinical mastitis in 15 dairy herds. Page 1059 in Proc. 12th World Congr. Dis. Cattle, Amsterdam, The Netherlands. World Assoc. Buiatrics, Toulouse, France.
84. Roberson, J. R. 2003. Establishing treatment protocols for clinical mastitis. Vet. Clin. North Am. Food Anim. Pract. 19:223-234.
85. Sampimon, O. C., and J. Sol. 2005. Efficacy of a cloxacillin dry cow product for treatment of heifers on farms with a low and a high prevalence of heifer mastitis in The Netherlands. Pages 278-284 in Proc. 4th Int. Dairy Fed. Mastitis Seminar, Maastricht, The Netherlands. Int. Dairy Fed., Brussels, Belgium.
86. Sandholm, M. 1995. A critical view on antibacterial mastitis therapy. Pages 169-186 in The hovine udder and mastitis. M. Sandholm, T. Honkanen-Buzalski, L. Kaartinen, and S. Pyörälä, ed. Gummerus Press, Javäskylä, Finland.
87. Schällibaum, M., J. Nicolet, and J. Bosson. 1981. Treatment of chronic subclinical staphylococcal mastitis in lactating cows by administrating high doses of spiramycin. Schweiz. Arch. Tierheilkd. 123:277-292. [In German]
88. Schukken, Y. H., and H. A. Deluyker. 1995. Design of field trials for the evaluation of antibacterial products for therapy of bovine clinical mastitis. J. Vet. Pharmacol. Ther. 18:274-283.
89. Schukken, Y. H., Y. T. Gröhn, B. McDermott, and J. J. McDermott. 2003a. Analysis of correlated discrete observations: Background, examples and solutions. Prev. Vet. Med. 59:223-240.
90. Schukken, Y. H., D. J. Wilson, F. Welcome, L. Garrison-Tikofsky, and R. N. Gonzalez. 2003b. Monitoring udder health and milk quality using somatic cell counts. Vet. Res. 34:579-596.
91. Sears, P. 2002. Staphylococcal vaccines: What are the new strategies? Pages 86-92 in Proc. 41st Ann. Mtg. Natl. Mastitis Counc., Orlando, Florida. Natl. Mastitis Counc. Inc., Madison, WI.
92. Sears, P. M., and A. P. Belschner. 1999. Alternative management and economic considerations in Staphylococcus aureus elimination programs. Pages 86-92 in Proc. 38th Ann. Mtg. Natl. Mastitis Counc., Arlington, VA. Natl. Mastitis Counc. Inc., Madison, WI.
93. Sears, P. M., and K. K. McCarthy. 2003. Management and treatment of staphylococcal mastitis. Vet. Clin. North Am. Food Anim. Pract. 19:171-185.
94. Sears, P. M., B. S. Smith, P. B. English, P. S. Herer, and R. N. Gonzalez. 1990. Shedding pattern of Staphylococcus aureus from bovine intramammary infections. J. Dairy Sci. 72:1900-1906.
95. Sears, P. M., D. J. Wilson, R. N. Gonzalez, and D. D. Hancock. 1991. Microbiological results from milk samples obtained premilking and postmilking for the diagnosis of bovine intramammary infections. J. Dairy Sci. 74:4183-4188.
96. Seegers, H., C. Fourichon, D. Billon, and P. Hortet. 2004. Cost-benefit analysis of mastitis control by simulation: Model description and profitability of strategies targeting subclinically infected cows. Pages 179-186 in Proc. Soc. Vet. Epidemiol. Prev. Med., Martigny, Switzerland. Soc. Vet. Epidemiol. Prev. Med., www.svepm.org.uk
97. Sérieys, F., Y. Raguet, L. Goby, H. Schmidt, and G. Friton. 2005. Comparative efficacy of local and systemic antibiotic treatment in lactating cows with clinical mastitis. J. Dairy Sci. 88:93-99.
98. Shephard, R. W., J. Malmo, and D. U. Pfeiffer. 2000. A clinical trial to evaluate the effectiveness of antibiotic treatment of lactating cows with high somatic cell counts in their milk. Aust. Vet. J. 78:763-768.
99. Shephard, R. W., S. Burman, and P. Marcun. 2004. A comparative field trial of cephalonium and cloxacillin for dry cow therapy for mastitis in Australian dairy cows. Aust. Vet. J. 82:624-629.
100. Smith, T. H., L. K. Fox, and J. R. Middleton. 1998. Outbreak of mastitis caused by one strain of Staphylococcus aureus in a closed dairy herd. J. Am. Vet. Med. Assoc. 212:553-556.
101. Smith, E. M., L. E. Green, G. F. Medley, H. E. Bird, L. K. Fox, Y. H. Schukken, J. V. Kruze, A. J. Bradley, R. N. Zadoks, and C. G. Dowson. 2005. Multilocus sequence typing of intercontinental bovine Staphylococcus aureus isolates. J. Clin. Microbiol. 43:4737-4743.
102. Sol, J., O. C. Sampimon, H. W. Barkema, and Y. H. Schukken. 2000. Factors associated with cure after therapy of clinical mastitis caused by Staphylococcus aureus. J. Dairy Sci. 83:278-284.
103. Sol, J., O. C. Sampimon, E. Hartman, and H. W. Barkema. 2002. Effect of preculture freezing and incubation on bacteriological isolation from subclinical mastitis samples. Vet. Microbiol. 85:241-249.
104. Sol, J., O. C. Sampimon, J. J. Snoep, and Y. H. Schukken. 1994. Factors associated with bacteriological cure after dry cow treatment of subclinical Staphylococcus aureus mastitis with antibiotics. J. Dairy Sci. 77:75-79.
105. Sol, J., O. C. Sampimon, J. J. Snoep, and Y. H. Schukken. 1997. Factors associated with bacteriological cure during lactation after therapy for subclinical mastitis caused by Staphylococcus aureus. J. Dairy Sci. 80:2803-2808.
106. Sordillo, L. M., S. C. Nickerson, and R. M. Akers. 1989. Pathology of Staphylococcus aureus mastitis during lactogenesis: Relationships with bovine mammary structure and function. J. Dairy Sci. 72:228-240.
107. St. Rose, S. G., J. M. Swinkels, W. D. Kremer, C. L. Kruitwagen, and R. N. Zadoks. 2003. Effect of penethamate hydriodide treatment on bacteriological cure, somatic cell count and milk production of cows and quarters with chronic subclinical Streptococcus uberis or Streptococcus dysgalactiae infection. J. Dairy Res. 70:387-394.
108. Struelens, M. J., Y. De Gheldre, and A. Deplano. 1998. Comparative and library epidemiological typing systems: Outbreak investigations versus surveillance systems. Infect. Control Hosp. Epidemiol. 19:565-569.
109. Swinkels, J. M., R. G. Rooijendijk, H. Hogeveen, and R. N. Zadoks. 2005. Economic benefits of lactational treatment of subclinical Staphylococcus aureus mastitis. J. Dairy Sci. 88:4273-4287.
110. Takahashi, H., T. Komatsu, K. Hodate, R. Horino, and Y. Yokomizo. 2005. Effect of intramammary injection of RbIL-8 on milk levels of somatic cell count, chemiluminescence activity and shedding patterns of total bacteria and Staph. aureus in Holstein cows with naturally infected subclinical mastitis. J. Vet. Med. B Infect. Dis. Vet. Public Health 52:32-37.
111. Taponen, S., K. Dredge, B. Henriksson, A. M. Pyyhtia, L. Suojala, R. Junni, K. Heinonen, and S. Pyörälä. 2003a. Efficacy of intramammary treatment with procaine penicillin G vs. procaine penicillin G plus neomycin in bovine clinical mastitis caused by penicillin-susceptible, gram-positive bacteria-A double blind field study. J. Vet. Pharmacol. Ther. 26:193-198.
112. Taponen, S., A. Jantunen, E. Pyörälä, and S. Pyörälä. 2003b. Efficacy of targeted 5-day combined parenteral and intramammary treatment of clinical mastitis caused by penicillin-susceptible or penicillin-resistant Staphylococcus aureus. Acta Vet. Scand. 44:53-62.
113. Thorburn, M. A. 1990. General principles for the design of clinical trials with special reference to mastitis therapy. IDF Bull. 247:39-48.
114. Tikofsky, L. L., J. W. Barlow, C. Santisteban, and Y. H. Schukken. 2003. A comparison of antimicrobial susceptibility patterns for Staphylococcus aureus in organic and conventional dairy herds. Microb. Drug Resist. 9(Suppl. 1):S39-S45.
115. Tikofsky, L. L., and R. N. Zadoks. 2005. An alternative treatment trial for Staphylococcus aureus mastitis in organically managed dairy cattle. Pages 358-363 in Proc. 4th Int. Dairy Fed. Mastitis Seminar, Maastricht, The Netherlands. Int. Dairy Fed., Brussels, Belgium.
116. Timms, L. L. 1995. Evaluation of pirlimycin for blitz therapy of chronic Staphylococcus aureus mastitis in dairy cows. Pages 140-141 in Proc. 34th Annu. Mtg Natl. Mastitis Counc., Fort Worth, TX. Natl. Mastitis Counc. Inc., Madison, WI.
117. Timms, L. L., M. Kirkpatrick, and P. Sears. 2000. Field trial evaluation of extended pirlimycin therapy with or without vaccination for Staphylococcus aureus mastitis. Pages 201-202 in Proc. 39th Annu. Mtg. Natl. Mastitis Counc., Atlanta, GA. Natl. Mastitis Counc., Inc., Madison, WI.
118. Ubeda, C., E. Maiques, E. Knecht, I. Lasa, R. P. Novick, and J. R. Penades. 2005. Antibiotic-induced SOS response promotes horizontal dissemination of pathogenicity island-encoded virulence factors in staphylococci. Mol. Microbiol. 56:836-844.
119. Ubeda, C., M. A. Tormo, C. Cucarella, P. Trotonda, T. J. Foster, I. Lasa, and J. R. Penades. 2003. Sip, an integrase protein with excision, circularization and integration activities, defines a new family of mobile Staphylococcus aureus pathogenicity islands. Mol. Microbiol. 49:193-210.
120. Van Eenennaam, A. L., I. A. Gardner, J. Holmes, L. Perani, R. J. Anderson, J. S. Cullor, and W. M. Guterbock. 1995. Financial analysis of alternative treatments for clinical mastitis associated with environmental pathogens. J. Dairy Sci. 78:2086-2095.
121. Vasudevan, P., M. K. Nair, T. Annamalai, and K. S. Venkitanarayanan. 2003. Phenotypic and genotypic characterization of bovine mastitis isolates of Staphylococcus aureus for biofilm formation. Vet. Microbiol. 92:179-185.
122. Wilson, D. J., R. N. Gonzalez, K. L. Case, L. L. Garrison, and Y. T. Gröhn. 1999. Comparison of seven antibiotic treatments with no treatment for bacteriological efficacy against bovine mastitis pathogens. J. Dairy Sci. 82:1664-1670.
123. Wilson, D. J., R. N. Gonzalez, and P. M. Sears. 1995. Segregation or use of separate milking units for cows infected with Staphylococcus aureus: Effects on prevalence of infection and bulk tank somatic cell count. J. Dairy Sci. 78:2083-2085.
124. Wraight, M. D. 2003. A comparative efficacy trial between cefuroxime and cloxacillin as intramammary treatments for clinical mastitis in lactating cows on commercial dairy farms. N.Z. Vet. J. 51:26-32.
125. Yamagata, M., W. J. Goodger, L. Weaver, and C. Franti. 1987. The economic benefit of treating subclinical Streptococcus agalactiae mastitis in lactating cows. J. Am. Vet. Med. Assoc. 191:1556-1561.
126. Yancey, R. J., M. S. Sanchez, and C. W. Ford. 1991. Activity of antibiotics against Staphylococcus aureus within polymorphonuclear neutrophils. Eur. J. Clin. Microbiol. Infect. Dis. 10:107-113.
127. Zadoks, R. N., H. G. Allore, H. W. Barkema, O. C. Sampimon, G. J. Wellenberg, Y. T. Gröhn, and Y. H. Schukken. 2001. Cow- and quarter-level risk factors for Streptococcus uberis and Staphylococcus aureus mastitis. J. Dairy Sci. 84:2649-2663.
128. Zadoks, R. N., H. G. Allore, T. J. Hagenaars, H. W. Barkema, and Y. H. Schukken. 2002a. A mathematical model of Staphylococcus aureus control in dairy herds. Epidemiol. Infect. 129:397-416.
129. Zadoks, R. N., W. B. van Leeuwen, H. W. Barkema, O. C. Sampimon, H. Verbrugh, Y. H. Schukken, and A. van Belkum. 2000. Application of pulsed-field gel electrophoresis and binary typing as tools in veterinary clinical microbiology and molecular epidemiology of bovine and human Staphylococcus aureus. J. Clin. Microbiol. 38:1931-1939.
130. Zadoks, R. N., W. B. Van Leeuwen, D. Kreft, L. K. Fox, H. W. Barkema, Y. H. Schukken, and A. van Belkum. 2002b. Comparison of Staphylococcus aureus isolates from bovine and human skin, milking equipment, and bovine milk by phage typing, pulsed-field gel electrophoresis, and binary typing. J. Clin. Microbiol. 40:3894-3902.
131. Zecconi, A., R. Piccinini, A. Zepponi, and G. Ruffo. 1997. Recovery of Staphylococcus aureus from centrifuged quarter milk samples. J. Dairy Sci. 80:3058-3063.
132. Zepeda, L., K. L. Buelow, K V. Nordlund, C. B. Thomas, M. T. Collins, and W. J. Goodger. 1998. A linear programming assessment of the profit from strategies to reduce the prevalence of Staphylococcus aureus mastitis. Prev. Vet. Med. 33:183-193.
133. Ziv, G., and M. Storper. 1985. Intramuscular treatment of subclinical staphylococcal mastitis in lactating cows with penicillin G, methicillin and their esters. J. Vet. Pharmacol. Ther. 8:276-283.